Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Biomed Research International|March 14, 2013
The Italian National External quality assessment program in molecular genetic testing: results of the VII round (2010-2011)F Censi, F Tosto, G Floridia, et al.Genetic Testing|January 23, 2003
Prevalence of the E1317Q variant of the APC gene in Italian patients with colorectal adenomasV Gismondi, L Bonelli, S Sciallero, et al.Breast Cancer Research and Treatment|March 8, 2013
Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in ItalyL Ottini, V Silvestri, C Saieva, et al.Breast Cancer Research and Treatment|November 12, 2014
Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in ItalyL Ottini, P Rizzolo, I Zanna, et al.Breast (Edinburgh, Scotland)|September 10, 2013
Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinicsL Varesco, V Viassolo, A Viel, et al.Journal of Medical Genetics|February 4, 2005
Classification of BRCA1 missense variants of unknown clinical significanceC M Phelan, V Dapic, B Tice, et al.British Journal of Cancer|September 11, 2008
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriersA Osorio, M Pollán, G Pita, et al.Journal of Medical Genetics|July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesA C Antoniou, P D P Pharoah, S Narod, et al.British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.American Journal of Human Genetics|April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesA Antoniou, P D P Pharoah, S Narod, et al.Pageof 8